Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons

Nature
|October 5, 1986
PubMed

Insights

Tumour necrosis factor-alpha (TNF-alpha) and TNF-beta exhibit antiviral properties, working with interferons (IFNs) to protect cells from viral infections. These tumour necrosis factors selectively kill virus-infected cells, independent of IFN induction.

Area of Science:

  • Immunology
  • Virology
  • Molecular Biology

Background:

  • Tumour necrosis factor (TNF) and lymphotoxin are structurally related proteins with similar biological activities.
  • Initially identified for their tumoricidal effects, their broader roles in immune responses were recognized.

Purpose of the Study:

  • To investigate the antiviral activities of TNF-alpha and TNF-beta.
  • To determine if TNF-alpha and TNF-beta synergize with interferons (IFNs) in antiviral defense.
  • To explore the mechanism of TNF-mediated antiviral effects.

Main Methods:

  • Treatment of diverse cell types with TNF-alpha and TNF-beta.
  • Co-treatment with interferons (IFNs).
  • Assessment of resistance to RNA and DNA virus infection.
  • Evaluation of TNF production in response to viral infection.

Main Results:

  • Both TNF-alpha and TNF-beta demonstrated significant antiviral activity against both RNA and DNA viruses.
  • TNF-alpha and TNF-beta synergized with IFNs to enhance viral resistance in various cell types.
  • The antiviral effects of TNFs were independent of induced IFN synthesis.
  • Virus-infected cells were selectively killed by TNFs, an effect accelerated by IFN-gamma.
  • Viral infection was found to induce the production of TNFs.

Conclusions:

  • TNF-alpha and TNF-beta possess potent antiviral activities.
  • TNFs play a crucial role in the innate immune response to viral infections.
  • The synergistic interaction between TNFs and IFNs enhances cellular defense against viruses.

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...